Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats

D. Nelson, Nathan Kuppermann, G. R. Fleisher, B. K. Hammer, C. M. Thompson, C. T. Garcia, T. J. Novitsky, J. Parsonnet, A. Onderdonk, G. R. Siber, R. A. Saladino

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Objective: A recombinant endotoxin neutralizing protein was evaluated for its ability to ameliorate the effects of Escherichia coli sepsis in rats. Design: Prospective, controlled animal trial. Setting: Hospital animal research laboratory. Subjects: Wistar rats, treated with gentamicin 1 hr after challenge with intraperitoneal E. coli O18ac. Interventions: The animals received a recombinant endotoxin neutralizing protein, in doses of 5, 25, or 50 mg/kg, either 30 or 60 mins after challenge; controls received saline. Measurements and Main Results: Geometric mean serum endotoxin concentrations in endotoxin neutralizing protein-treated animals did not differ from control animals. Tumor necrosis factor concentrations in animals treated with endotoxin neutralizing protein 30 mins after challenge were significantly lower than controls. Animals treated with 25 or 50 mg/kg of endotoxin neutralizing protein 30 mins after E. coli challenge had significant improvements in survival compared with controls. Animals treated with 50 mg/kg of endotoxin neutralizing protein 60 mins after E. coli challenge had significant improvements in survival compared with controls. Conclusion: Endotoxin neutralizing protein significantly reduces mortality from Gram-negative sepsis in an antibiotic-treatment model of E. coli peritonitis and bacteremia in rats, mediated by a neutralization of the biological effects of endotoxin.

Original languageEnglish (US)
Pages (from-to)92-98
Number of pages7
JournalCritical Care Medicine
Volume23
Issue number1
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Endotoxins
Sepsis
Escherichia coli
Proteins
Bacteremia
Gentamicins
Peritonitis
Wistar Rats
Tumor Necrosis Factor-alpha
Anti-Bacterial Agents
Mortality
Serum

Keywords

  • animal model
  • bacterial infection
  • critical illness
  • endotoxin
  • Escherichia coli
  • Gram-negative bacteria
  • sepsis
  • shock
  • tumor necrosis factor

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Nelson, D., Kuppermann, N., Fleisher, G. R., Hammer, B. K., Thompson, C. M., Garcia, C. T., ... Saladino, R. A. (1995). Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats. Critical Care Medicine, 23(1), 92-98. https://doi.org/10.1097/00003246-199501000-00017

Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats. / Nelson, D.; Kuppermann, Nathan; Fleisher, G. R.; Hammer, B. K.; Thompson, C. M.; Garcia, C. T.; Novitsky, T. J.; Parsonnet, J.; Onderdonk, A.; Siber, G. R.; Saladino, R. A.

In: Critical Care Medicine, Vol. 23, No. 1, 1995, p. 92-98.

Research output: Contribution to journalArticle

Nelson, D, Kuppermann, N, Fleisher, GR, Hammer, BK, Thompson, CM, Garcia, CT, Novitsky, TJ, Parsonnet, J, Onderdonk, A, Siber, GR & Saladino, RA 1995, 'Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats', Critical Care Medicine, vol. 23, no. 1, pp. 92-98. https://doi.org/10.1097/00003246-199501000-00017
Nelson, D. ; Kuppermann, Nathan ; Fleisher, G. R. ; Hammer, B. K. ; Thompson, C. M. ; Garcia, C. T. ; Novitsky, T. J. ; Parsonnet, J. ; Onderdonk, A. ; Siber, G. R. ; Saladino, R. A. / Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats. In: Critical Care Medicine. 1995 ; Vol. 23, No. 1. pp. 92-98.
@article{280765ae4f8f4dfb948750ef56f5461d,
title = "Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats",
abstract = "Objective: A recombinant endotoxin neutralizing protein was evaluated for its ability to ameliorate the effects of Escherichia coli sepsis in rats. Design: Prospective, controlled animal trial. Setting: Hospital animal research laboratory. Subjects: Wistar rats, treated with gentamicin 1 hr after challenge with intraperitoneal E. coli O18ac. Interventions: The animals received a recombinant endotoxin neutralizing protein, in doses of 5, 25, or 50 mg/kg, either 30 or 60 mins after challenge; controls received saline. Measurements and Main Results: Geometric mean serum endotoxin concentrations in endotoxin neutralizing protein-treated animals did not differ from control animals. Tumor necrosis factor concentrations in animals treated with endotoxin neutralizing protein 30 mins after challenge were significantly lower than controls. Animals treated with 25 or 50 mg/kg of endotoxin neutralizing protein 30 mins after E. coli challenge had significant improvements in survival compared with controls. Animals treated with 50 mg/kg of endotoxin neutralizing protein 60 mins after E. coli challenge had significant improvements in survival compared with controls. Conclusion: Endotoxin neutralizing protein significantly reduces mortality from Gram-negative sepsis in an antibiotic-treatment model of E. coli peritonitis and bacteremia in rats, mediated by a neutralization of the biological effects of endotoxin.",
keywords = "animal model, bacterial infection, critical illness, endotoxin, Escherichia coli, Gram-negative bacteria, sepsis, shock, tumor necrosis factor",
author = "D. Nelson and Nathan Kuppermann and Fleisher, {G. R.} and Hammer, {B. K.} and Thompson, {C. M.} and Garcia, {C. T.} and Novitsky, {T. J.} and J. Parsonnet and A. Onderdonk and Siber, {G. R.} and Saladino, {R. A.}",
year = "1995",
doi = "10.1097/00003246-199501000-00017",
language = "English (US)",
volume = "23",
pages = "92--98",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats

AU - Nelson, D.

AU - Kuppermann, Nathan

AU - Fleisher, G. R.

AU - Hammer, B. K.

AU - Thompson, C. M.

AU - Garcia, C. T.

AU - Novitsky, T. J.

AU - Parsonnet, J.

AU - Onderdonk, A.

AU - Siber, G. R.

AU - Saladino, R. A.

PY - 1995

Y1 - 1995

N2 - Objective: A recombinant endotoxin neutralizing protein was evaluated for its ability to ameliorate the effects of Escherichia coli sepsis in rats. Design: Prospective, controlled animal trial. Setting: Hospital animal research laboratory. Subjects: Wistar rats, treated with gentamicin 1 hr after challenge with intraperitoneal E. coli O18ac. Interventions: The animals received a recombinant endotoxin neutralizing protein, in doses of 5, 25, or 50 mg/kg, either 30 or 60 mins after challenge; controls received saline. Measurements and Main Results: Geometric mean serum endotoxin concentrations in endotoxin neutralizing protein-treated animals did not differ from control animals. Tumor necrosis factor concentrations in animals treated with endotoxin neutralizing protein 30 mins after challenge were significantly lower than controls. Animals treated with 25 or 50 mg/kg of endotoxin neutralizing protein 30 mins after E. coli challenge had significant improvements in survival compared with controls. Animals treated with 50 mg/kg of endotoxin neutralizing protein 60 mins after E. coli challenge had significant improvements in survival compared with controls. Conclusion: Endotoxin neutralizing protein significantly reduces mortality from Gram-negative sepsis in an antibiotic-treatment model of E. coli peritonitis and bacteremia in rats, mediated by a neutralization of the biological effects of endotoxin.

AB - Objective: A recombinant endotoxin neutralizing protein was evaluated for its ability to ameliorate the effects of Escherichia coli sepsis in rats. Design: Prospective, controlled animal trial. Setting: Hospital animal research laboratory. Subjects: Wistar rats, treated with gentamicin 1 hr after challenge with intraperitoneal E. coli O18ac. Interventions: The animals received a recombinant endotoxin neutralizing protein, in doses of 5, 25, or 50 mg/kg, either 30 or 60 mins after challenge; controls received saline. Measurements and Main Results: Geometric mean serum endotoxin concentrations in endotoxin neutralizing protein-treated animals did not differ from control animals. Tumor necrosis factor concentrations in animals treated with endotoxin neutralizing protein 30 mins after challenge were significantly lower than controls. Animals treated with 25 or 50 mg/kg of endotoxin neutralizing protein 30 mins after E. coli challenge had significant improvements in survival compared with controls. Animals treated with 50 mg/kg of endotoxin neutralizing protein 60 mins after E. coli challenge had significant improvements in survival compared with controls. Conclusion: Endotoxin neutralizing protein significantly reduces mortality from Gram-negative sepsis in an antibiotic-treatment model of E. coli peritonitis and bacteremia in rats, mediated by a neutralization of the biological effects of endotoxin.

KW - animal model

KW - bacterial infection

KW - critical illness

KW - endotoxin

KW - Escherichia coli

KW - Gram-negative bacteria

KW - sepsis

KW - shock

KW - tumor necrosis factor

UR - http://www.scopus.com/inward/record.url?scp=0028813850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028813850&partnerID=8YFLogxK

U2 - 10.1097/00003246-199501000-00017

DO - 10.1097/00003246-199501000-00017

M3 - Article

C2 - 8001394

AN - SCOPUS:0028813850

VL - 23

SP - 92

EP - 98

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 1

ER -